Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...
Giant raises in energy and defense contributed to a year almost as high as the 2021 boom, but a handful of early-stage ...
CNW/ - i-80 GOLD CORP. (TSX:IAU) (NYSE American:IAUX) ("i-80 Gold", or the "Company") is pleased to announce assay results ...
"Our financial performance in the third quarter reflected solid results, demonstrating our continued execution of our ...
Climate litigation faces limits due to procedural issues and courts’ inability to solve systemic problems. ADR—like mediation ...
From Portland’s Centennial neighborhood to Gresham and Happy Valley, there are people who can't afford to live in those areas ...
From December 9 to 12, 2025, the Clerc Center welcomed a joint accreditation team from the Middle States Association ...
Shrub Oak International School is proud to highlight its Music Education Program, a unique and highly individualized offering ...
Legislation introduced in the Mississippi House of Representatives would set up “Magnolia Student Accounts” (MSA), an ...
ProBioGen has signed a Master Service Agreement with Zag Bio Inc., a biotechnology company developing thymus-targeted ...
Plainview Herald on MSN
Amarillo EnterPrize Challenge launches with half-million in business funding
AMARILLO - Orientations began Tuesday for the 2026 Amarillo EnterPrize Challenge, which involves business owners in Potter and Randall counties competing to share in a $500,000 prize pool. Space in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback